Status:
COMPLETED
Treatment of Alopecia Areata of the Scalp With Intradermal Injections of Botulinum Toxin
Lead Sponsor:
University of British Columbia
Conditions:
Alopecia Areata
Eligibility:
All Genders
19-65 years
Phase:
NA
Brief Summary
The purpose of this study is to examine prospectively the safety and efficacy of Botulinum Toxin A (Botox) injections in the treatment of patients with alopecia areata of the scalp.
Detailed Description
Hypothesis Intralesional injections of Botulinum Toxin A can be used as a treatment for AA. Potential points of action of this treatment include changes in neurotransmitters, which either directly or ...
Eligibility Criteria
Inclusion
- Patients with long standing alopecia areata, patches must be at least 4 cm in diameter
Exclusion
- Intake of drugs that interfere with Botulinum toxin A such as gentamicin, tobramycin, clindamycin and lincomycin; medications used to treat heart rhythm problems, such as quinidine; and medications used to treat other conditions, such as myasthenia gravis, ALS or Alzheimer's disease.
- Neuromuscular disorders such as Myasthenia gravis and Lambert-Eaton-Syndrome.
- Treatment with another investigational drug within 4 weeks prior to anticipated first treatment.
- Females who are pregnant, planning to become pregnant during the study period, or breastfeeding.
Key Trial Info
Start Date :
October 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 30 2009
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00408798
Start Date
October 1 2007
End Date
October 30 2009
Last Update
March 3 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Dermatology, The Skin Care Centre
Vancouver, British Columbia, Canada, V5Z 4E8